Duloxetine for the Treatment of Dysthymia
Completed · Not applicable
Conditions studied: Depressive Disorder
In brief
The purpose of this study is to test the hypothesis that duloxetine (Cymbalta), in doses of 60 or 120 mg/day, is an effective and tolerable treatment for adult outpatients suffering from dysthymia. Dysthymia is chronic, mild depression characterized by feeling sad or low more days than not for more than 2 years.
Key facts
- Study ID
- NCT00185575
- Run by
- Stanford University
- People needed
- 24
- Starts
- 2004-09-01
- Expected to finish
- 2006-04-01
- Last updated by the study team
- 2009-04-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.